CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Shares withheld for taxes Director gave up 880 shares (to pay taxes)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 219 shares (to pay taxes)
- 4 Open-market sale Principal Accounting Officer sold 2,427 shares at $53.37 ($129,529)
- 4 Shares withheld for taxes Principal Accounting Officer gave up 1,163 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 819 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 886 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 2,534 shares (to pay taxes)
- 4 Open-market sale Chief Medical Officer sold 7,100 shares at $50.16 ($356,112)
- 4 Open-market sale Chief Medical Officer sold 621 shares at $50.02 ($31,063)
- 4 Open-market sale Chief Medical Officer sold 49,638 shares at an average $50.08 ($2,485,989)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Principal Accounting Officer sold 2,950 shares at $50.09 ($147,766)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 40,322 shares at $31.00 ($1,249,982)
- 4 Open-market buy Director bought 8,064 shares at $31.00 ($249,984)
- 4 Open-market buy 10% owner bought 403,225 shares at $31.00 ($12,499,975)
- 4 Gift Director gave 5,000 shares (gift)
Page 17 of 38 · 758 filings